vs

Side-by-side financial comparison of AdvanSix Inc. (ASIX) and DigitalOcean Holdings, Inc. (DOCN). Click either name above to swap in a different company.

AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $242.4M, roughly 1.5× DigitalOcean Holdings, Inc.). DigitalOcean Holdings, Inc. runs the higher net margin — 10.6% vs -0.8%, a 11.4% gap on every dollar of revenue. On growth, DigitalOcean Holdings, Inc. posted the faster year-over-year revenue change (18.3% vs 9.4%). AdvanSix Inc. produced more free cash flow last quarter ($36.1M vs $31.1M). Over the past eight quarters, DigitalOcean Holdings, Inc.'s revenue compounded faster (14.5% CAGR vs 3.4%).

AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.

DigitalOcean Holdings, Inc. is an American multinational technology company and cloud service provider. The company is headquartered in Broomfield, Colorado, US, with 15 globally distributed data centers. DigitalOcean provides developers, startups, and SMBs with cloud infrastructure-as-a-service platforms.

ASIX vs DOCN — Head-to-Head

Bigger by revenue
ASIX
ASIX
1.5× larger
ASIX
$359.9M
$242.4M
DOCN
Growing faster (revenue YoY)
DOCN
DOCN
+8.9% gap
DOCN
18.3%
9.4%
ASIX
Higher net margin
DOCN
DOCN
11.4% more per $
DOCN
10.6%
-0.8%
ASIX
More free cash flow
ASIX
ASIX
$5.0M more FCF
ASIX
$36.1M
$31.1M
DOCN
Faster 2-yr revenue CAGR
DOCN
DOCN
Annualised
DOCN
14.5%
3.4%
ASIX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASIX
ASIX
DOCN
DOCN
Revenue
$359.9M
$242.4M
Net Profit
$-2.8M
$25.7M
Gross Margin
7.6%
58.7%
Operating Margin
-0.7%
16.0%
Net Margin
-0.8%
10.6%
Revenue YoY
9.4%
18.3%
Net Profit YoY
-892.9%
40.5%
EPS (diluted)
$-0.11
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASIX
ASIX
DOCN
DOCN
Q4 25
$359.9M
$242.4M
Q3 25
$374.5M
$229.6M
Q2 25
$410.0M
$218.7M
Q1 25
$377.8M
$210.7M
Q4 24
$329.1M
$204.9M
Q3 24
$398.2M
$198.5M
Q2 24
$453.5M
$192.5M
Q1 24
$336.8M
$184.7M
Net Profit
ASIX
ASIX
DOCN
DOCN
Q4 25
$-2.8M
$25.7M
Q3 25
$-2.6M
$158.4M
Q2 25
$31.4M
$37.0M
Q1 25
$23.3M
$38.2M
Q4 24
$352.0K
$18.3M
Q3 24
$22.3M
$32.9M
Q2 24
$38.9M
$19.1M
Q1 24
$-17.4M
$14.1M
Gross Margin
ASIX
ASIX
DOCN
DOCN
Q4 25
7.6%
58.7%
Q3 25
6.8%
59.6%
Q2 25
14.3%
59.9%
Q1 25
14.2%
61.4%
Q4 24
3.4%
57.1%
Q3 24
14.4%
60.2%
Q2 24
17.9%
61.0%
Q1 24
0.9%
60.7%
Operating Margin
ASIX
ASIX
DOCN
DOCN
Q4 25
-0.7%
16.0%
Q3 25
-0.9%
19.6%
Q2 25
7.7%
16.3%
Q1 25
7.7%
17.9%
Q4 24
-3.9%
15.9%
Q3 24
7.5%
12.4%
Q2 24
11.5%
11.6%
Q1 24
-7.0%
6.2%
Net Margin
ASIX
ASIX
DOCN
DOCN
Q4 25
-0.8%
10.6%
Q3 25
-0.7%
69.0%
Q2 25
7.7%
16.9%
Q1 25
6.2%
18.1%
Q4 24
0.1%
8.9%
Q3 24
5.6%
16.6%
Q2 24
8.6%
9.9%
Q1 24
-5.2%
7.7%
EPS (diluted)
ASIX
ASIX
DOCN
DOCN
Q4 25
$-0.11
$0.23
Q3 25
$-0.10
$1.51
Q2 25
$1.15
$0.39
Q1 25
$0.86
$0.39
Q4 24
$0.02
$0.21
Q3 24
$0.82
$0.33
Q2 24
$1.43
$0.20
Q1 24
$-0.65
$0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASIX
ASIX
DOCN
DOCN
Cash + ST InvestmentsLiquidity on hand
$19.8M
$254.5M
Total DebtLower is stronger
$1.3B
Stockholders' EquityBook value
$815.2M
$-28.7M
Total Assets
$1.7B
$1.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASIX
ASIX
DOCN
DOCN
Q4 25
$19.8M
$254.5M
Q3 25
$23.7M
$236.6M
Q2 25
$18.4M
$387.7M
Q1 25
$8.3M
$360.4M
Q4 24
$19.6M
$428.4M
Q3 24
$17.3M
$439.9M
Q2 24
$12.1M
$443.1M
Q1 24
$20.6M
$419.1M
Total Debt
ASIX
ASIX
DOCN
DOCN
Q4 25
$1.3B
Q3 25
$1.3B
Q2 25
Q1 25
Q4 24
$1.5B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ASIX
ASIX
DOCN
DOCN
Q4 25
$815.2M
$-28.7M
Q3 25
$818.2M
$-69.6M
Q2 25
$823.7M
$-175.2M
Q1 25
$794.4M
$-210.7M
Q4 24
$774.6M
$-203.0M
Q3 24
$766.4M
$-211.7M
Q2 24
$746.6M
$-253.8M
Q1 24
$713.2M
$-286.1M
Total Assets
ASIX
ASIX
DOCN
DOCN
Q4 25
$1.7B
$1.8B
Q3 25
$1.7B
$1.7B
Q2 25
$1.6B
$1.7B
Q1 25
$1.6B
$1.6B
Q4 24
$1.6B
$1.6B
Q3 24
$1.5B
$1.5B
Q2 24
$1.5B
$1.5B
Q1 24
$1.5B
$1.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASIX
ASIX
DOCN
DOCN
Operating Cash FlowLast quarter
$63.7M
$57.3M
Free Cash FlowOCF − Capex
$36.1M
$31.1M
FCF MarginFCF / Revenue
10.0%
12.8%
Capex IntensityCapex / Revenue
7.7%
10.8%
Cash ConversionOCF / Net Profit
2.23×
TTM Free Cash FlowTrailing 4 quarters
$6.4M
$180.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASIX
ASIX
DOCN
DOCN
Q4 25
$63.7M
$57.3M
Q3 25
$26.6M
$95.8M
Q2 25
$21.1M
$92.4M
Q1 25
$11.4M
$64.1M
Q4 24
$64.2M
$71.3M
Q3 24
$57.3M
$73.4M
Q2 24
$50.2M
$71.3M
Q1 24
$-36.2M
$66.7M
Free Cash Flow
ASIX
ASIX
DOCN
DOCN
Q4 25
$36.1M
$31.1M
Q3 25
$66.0K
$88.0M
Q2 25
$-7.2M
$59.3M
Q1 25
$-22.6M
$2.1M
Q4 24
$29.8M
$26.1M
Q3 24
$26.8M
$16.0M
Q2 24
$16.7M
$39.5M
Q1 24
$-71.6M
$23.0M
FCF Margin
ASIX
ASIX
DOCN
DOCN
Q4 25
10.0%
12.8%
Q3 25
0.0%
38.3%
Q2 25
-1.7%
27.1%
Q1 25
-6.0%
1.0%
Q4 24
9.1%
12.7%
Q3 24
6.7%
8.1%
Q2 24
3.7%
20.5%
Q1 24
-21.3%
12.5%
Capex Intensity
ASIX
ASIX
DOCN
DOCN
Q4 25
7.7%
10.8%
Q3 25
7.1%
3.4%
Q2 25
6.9%
15.2%
Q1 25
9.0%
29.4%
Q4 24
10.4%
22.1%
Q3 24
7.7%
28.9%
Q2 24
7.4%
16.6%
Q1 24
10.5%
23.6%
Cash Conversion
ASIX
ASIX
DOCN
DOCN
Q4 25
2.23×
Q3 25
0.60×
Q2 25
0.67×
2.50×
Q1 25
0.49×
1.68×
Q4 24
182.29×
3.91×
Q3 24
2.57×
2.23×
Q2 24
1.29×
3.73×
Q1 24
4.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASIX
ASIX

Plant Nutrients$140.0M39%
Chemical Intermediates$92.8M26%
Caprolactam$64.4M18%
Nylon Resins$62.8M17%

DOCN
DOCN

Scalers$84.3M35%
Scalers Plus$69.9M29%
Builders$64.1M26%
Learners Testers And Other$24.1M10%

Related Comparisons